Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket

Gainers

• Secoo Holding Limited SECO rose 44% to $1.44 in pre-market trading after dipping over 31% on Friday.
• Entera Bio Ltd. ENTX rose 43.1% to $1.46 in pre-market trading after dropping 5% on Friday. Entera Bio recently announced the FDA's acceptance of a Type D meeting review to affirm design of the pivotal, Phase 3 protocol for EB613 PTH mini tablets, as the first oral osteoanabolic treatment of post-menopausal osteoporosis.
• BuzzFeed, Inc. BZFD rose 20.7% to $1.87 in pre-market trading. BuzzFeed is expected to release its Q4 financial results on Monday, March 13, 2023, after the closing bell.
• BYND Cannasoft Enterprises Inc. BCAN rose 12.5% to $2.80 in pre-market trading after declining around 3% on Friday.
• Sono Group N.V. SEV rose 12.5% to $0.8301 in pre-market trading after gaining over 10% on Friday. Sono Group recently announced it will focus exclusively on its solar tech company and has terminated the Sion program.
• Troika Media Group, Inc. TRKA rose 10.6% to $0.57 in pre-market trading after dropping over 4% on Friday.
• Kala Pharmaceuticals, Inc. KALA rose 8.6% to $18.19 in pre-market trading after surging around 65% on Friday. Kala Pharmaceuticals recently said Q4 adjusted EPS results were higher year over year.
• EUDA Health Holdings Limited EUDA shares rose 8.2% to $1.45 in pre-market trading after jumping more than 20% on Friday
• Seer, Inc. SEER shares rose 6.8% to $5.82 in pre-market trading after surging over 29% on Friday. Seer recently reported better-than-expected Q4 EPS and sales results.
• Hertz Global Holdings, Inc. HTZ shares rose 4.7% to $19.65 in pre-market trading. Hertz Global will replace Pebblebrook Hotel Trust in the S&P MidCap 400 effective Monday, March 20.

Losers

• Rubius Therapeutics, Inc. RUBY fell 36% to $0.08 in pre-market after gaining 10% on Friday.
• Esperion Therapeutics, Inc. ESPR fell 30.7% to $4.38 in pre-market trading after the company reported the full results from the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting Regimen (CLEAR) Outcomes trial, which were presented at the American College of Cardiology’s Annual Scientific Session & Expo together with the World Congress of Cardiology and simultaneously published in the New England Journal of Medicine..
• Alzamend Neuro, Inc. ALZN shares dropped 28.6% to $0.40 in pre-market trading after gaining around 3% on Friday.
• Assure Holdings Corp. IONM fell 24.5% to $3.50 in pre-market trading. Assure shares dropped over 22% on Friday after the company announced a 1-for-20 reverse stock split..
• Sesen Bio, Inc. SESN fell 15.8% to $0.5190 in pre-market trading. Sesen Bio Stockholders recently approved merger with Carisma Therapeutics.
• Vivos Therapeutics, Inc. VVOS shares fell 11.8% to $0.3810 in pre-market trading after gaining 11% on Friday. Vivos Therapeutics recently acquired product rights and patents from Advanced Facialdontics, LLC.
• Performance Shipping Inc. PSHG shares fell 11.7% to $0.98 in pre-market trading. Performance Shipping recently reported pricing of $12.5 million registered direct offering.
• ObsEva SA OBSV fell 8.7% to $0.21 in pre-market trading. ObsEva shares jumped 117% on Friday following the purchase of 4 million shares by a company director.
• Curis, Inc. CRIS fell 8.6% to $0.6301 in pre-market trading. Curis is expected to release its Q4 financial results on Thursday, March 9, 2023.
• Acutus Medical, Inc. AFIB fell 8.3% to $1.10 in pre-market trading after dropping 11% on Friday. Acutus Medical recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4).

Now Read This: Investor Optimism Improves After Dow Snaps 4-Week Losing Streak